Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Wegovy was recently approved by the FDA to treat weight loss for individuals with a BMI of 30 or higher (considered the obese category) and individuals with an overweight BMI (25 - 30) who also have a weight-related comorbidity (high blood pressure, high cholesterol, fatty liver disease, etc.)
It is the first study, to our knowledge, to investigate how stigma directed at GLP-1 users compares to stigma directed at higher-weight people, and it offers a timely examination of the stigma associated with regaining weight after discontinuing a GLP-1
Most GLP-1RAs are administered via subcutaneous injections, although oral semaglutide is available
The Effect of Daily Intake of Selenium, Vitamin E and Folic Acid on Sperm Parameters in Males with Idiopathic Infertility: A Single-Blind Randomized Controlled Clinical Trial
US$ 22.90
US$ 22.34
US$ 21.12
US$ 25.73
